10/19/2014

BioGaming

Gamification platform for the physical therapy

BioGaming raises $3 million to bring its gamification platform to the physical therapy market. TriVentures and First-Time lead the round, together with existing investors.
Tel Aviv, Israel – BioGaming Ltd. a leader in creating gamification solution for therapeutic purposes announced that it had completed an A round totaling $3M. The funds will fuel the company's commercialization efforts in Europe, the US and Israel.
One of the key challenges in rehabilitation is patient lack of compliance with unsupervised exercise assignments. Developed by physical therapists for physical therapists, BioGaming’s solution is the first user-friendly, engaging, cost-effective, and professional tool that motivates patients to actually perform their exercises, and to do so correctly. BioGaming's advanced sensing and analysis tools enables exercising at home while being monitored and supervised.
BioGaming provides the therapist with an intuitive, cloud-based dashboard to design the patient’s exercise program. Using advanced, proprietary algorithms, the program is automatically translated into personalized, interactive and fun games that motivate the patient to adhere to the program – and thus speed up the rehabilitation process. Standard third-party game consoles and 3D sensors monitor the patient’s performance so that the patient can get immediate feedback and the therapist can be alerted to potential problems.
According to Michal Geva, Managing Partner at TriVentures “Empowering patients and enhancing compliance are critical components in the drive to lower healthcare costs and improve outcomes. BioGaming’s unique interactive gamification platform dramatically increases patient adherence to home-based therapy assignments, while leaving full control over the rehabilitation process in the hands of the therapists.”
Dudi Klein, BioGaming's CEO stated that “we are very happy to have premier investors such as TriVentures and First-Time join the BioGaming family. With the capital raised and with the ongoing support of our investors and board members, we are on our way to launching our unique platform in the USA, Europe and Israel.”